Back

Design of a national Swedish study evaluating donor-derived cell-free DNA as a diagnostic biomarker in heart transplantation using next-generation sequencing

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Hemodynamics, prognostic markers, and precision monitoring in structural heart disease and heart transplantation Transplantation Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Ida Haugen Loefman

Karolinska University Hospital, Stockholm (Sweden)

6 More presentations in this session

Presentation thumbnail
Survival trajectories in post-transplant patients receiving "acceptably" undersized donor hearts: a long-term analysis
Doctor S. Kumar (Cambridge, GB)
Abstract
Presentation thumbnail
Predictors of heart failure rehospitalization in mitral transcatheter edge-to-edge repair (M-TEER) based on residual mitral regurgitation: a single center study
Doctor M. Biswas (Pittsburgh, US)
Abstract
Presentation thumbnail
Endocarditis by candida spp and association with heart failure: a systematic review of case reports
Doctor C. Vigil Lopez (Ensenada, MX)
Abstract
Presentation thumbnail
Persistent pulmonary hypertension after mitral valve surgery is related to post-operative adverse in-hospital events and mortality.
Miss R. Heijting (Amsterdam, NL)
Abstract
Presentation thumbnail
Predictors of lv function recovery one year after TAVR
Doctor F. Nascimento Ferreira (Lisbon, PT)
Abstract

Access the full session

Session thumbnail
Hemodynamics, prognostic markers, and precision monitoring in structural heart disease and heart transplantation

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026
You may be interested in
thumbnail
Congress Presentation
Silent threats and strategic solutions: surgical revascularization in diffuse cardiac allograft vasculopathy
thumbnail
Congress Presentation
Comprehensive non-invasive versus invasive approach to evaluate cardiac allograft vasculopathy in heart transplantation
thumbnail
Congress Presentation
New insights into long-term outcomes after heart transplantation: cancer and vasculopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources